Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 16 of 16 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
 |
Company Ardeal Pharma Inc. | Activity: Research and Development | Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. | Location Brevard |
| |
Company Ardeal Research Institute | Activity: Research and Development | Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. | Location Brevard |
| |
Company Balanced Pharma Inc. | Activity: Research and Development | Company Description Balanced Pharma is developing pH-balanced (buffered) injectable anesthetic drugs with enhanced usability qualities for use in dental and dermatological surgery. | Location Cornelius |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville |
| |
Company BMI OrganBank | Activity: Research and Development | Company Description BMI OrganBank develops products for ex vivo perfusion and preservation of organs and tissue. | Location Denver |
| |
Company Countervail Corp. | Activity: Research and Development | Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. | Location Mint Hill |
| |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington |
| |
Company Kartha Pharmaceuticals Inc. | Activity: Research and Development | Company Description Kartha Pharmaceuticals develops and commercializes pharmaceutical products. | Location Matthews |
| |
Company MD Scientific LLC | Activity: Research and Development | Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. | Location Charlotte |
| |
Company Milestone Pharmaceuticals USA Inc. | Activity: Research and Development | Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. | Location Charlotte |
| |
Company ML Bio Solutions Inc. | Activity: Research and Development | Company Description ML Bio Solutions is developing an oral treatment for patients with limb girdle muscular dystrophy 2i. | Location Charlotte |
| |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte |
| |
Company Phenom Pharmaceuticals LLC | Activity: Research and Development | Company Description Phenom Pharmaceuticals develops preventatives and therapeutics. | Location Charlotte |
| |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte |